TPP Healthcare and Partners hosted 1000+ investor and strategic partnering meetings with notable Asian investors at 2018 JP Morgan Health Care Week in San Francisco I’m still coming off the high of our successful cross-border corporate venturing and financing event we hosted last month with some of our top partners. Noting the need for people […]
News Round Up! My Communications Team recently flagged some articles I thought I’d share. Outside of the CFDA publishing a draft Decision for Adjusting the Administrative Regime for Import Drug Registrations, there is a lot of movement in the cross-border healthcare front… The Wall Street Journal: China Emerges as Powerhouse for Biotech Drugs Drugs are classified into two major categories based […]
Today I had the honor of speaking at the annual Chinese Pharmaceutical Enterprises Association (CPEA) Meeting. Key talking points were: Why is China relevant to my NA/EU clients: The importance of the Chinese healthcare market and Chinese capital to the outside world. Why Chinese should invest in these overseas markets: I stressed the real opportunity […]
News Round Up! FierceBiotech: Donald Trump’s First 100 Days, and beyond, for BiopharmaThe article looks at what the next four years could mean for the biopharma industry through Trump’s picks for healthcare top jobs and the power his policies will have over regulatory terms and drug pricing. BioSpectrum Asia: China Will Continue to Rise as a Key Base […]
For those of you who joined us last month, a warm thank you is owed. Our TPP Healthcare China Partnering Forum during JPM Healthcare Week was a homerun. The numbers: 300 attendees throughout the week, 500 live-stream registrants in China, 80 panelists, 60+ gallons of coffee, endless one-on-one meetings in our private ballrooms and 8K+ impressions […]